Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
HN
Humanin is a mitochondrial-derived peptide encoded within the 16S ribosomal RNA gene. It was discovered through its ability to protect neurons from Alzheimer's disease-related toxicity and is studied for neuroprotection, metabolic regulation, and anti-aging applications.
Humanin binds to FPRL1 (formyl peptide receptor-like 1) and BAX protein, inhibiting mitochondrial apoptosis in stressed cells. It also activates the STAT3 pathway and interacts with IGFBP-3, modulating IGF-1 signaling. In the brain, it protects neurons from amyloid-beta toxicity and oxidative stress through both intracellular and extracellular mechanisms.
Preclinical studies demonstrate neuroprotection against Alzheimer's-related amyloid-beta peptides, reduced atherosclerosis in ApoE-knockout mice, and improved metabolic function in diabetic models. Circulating humanin levels decline with age and correlate with cognitive function. Human clinical trials have not yet been conducted.
Typical Dose
1–5 mg
Frequency
Once daily or every other day
Route
SubQ
Notes
Dosing protocols are extrapolated from animal studies. The S14G-Humanin analog (HNG) is 1000x more potent than native humanin. Cycles and optimal duration are not established. Research context only — no clinical dosing guidelines exist.
Build a protocol with Humanin, schedule blood work for key biomarkers, and track your results.
Build Protocol with HumaninThis platform provides informational tools only, not medical advice. This information is for educational purposes only. Consult a licensed provider.